Literature DB >> 25332110

Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons.

Yong Ren1, Houbo Jiang, Zhixing Hu, Kevin Fan, Jun Wang, Stephen Janoschka, Xiaomin Wang, Shaoyu Ge, Jian Feng.   

Abstract

Parkinson's disease (PD) is characterized by the degeneration of nigral dopaminergic (DA) neurons and non-DA neurons in many parts of the brain. Mutations of parkin, an E3 ubiquitin ligase that strongly binds to microtubules, are the most frequent cause of recessively inherited PD. The lack of robust PD phenotype in parkin knockout mice suggests a unique vulnerability of human neurons to parkin mutations. Here, we show that the complexity of neuronal processes as measured by total neurite length, number of terminals, number of branch points, and Sholl analysis was greatly reduced in induced pluripotent stem cell (iPSC)-derived TH(+) or TH(-) neurons from PD patients with parkin mutations. Consistent with these, microtubule stability was significantly decreased by parkin mutations in iPSC-derived neurons. Overexpression of parkin, but not its PD-linked mutant nor green fluorescent protein, restored the complexity of neuronal processes and the stability of microtubules. Consistent with these, the microtubule-depolymerizing agent colchicine mimicked the effect of parkin mutations by decreasing neurite length and complexity in control neurons while the microtubule-stabilizing drug taxol mimicked the effect of parkin overexpression by enhancing the morphology of parkin-deficient neurons. The results suggest that parkin maintains the morphological complexity of human neurons by stabilizing microtubules.
© 2014 AlphaMed Press.

Entities:  

Keywords:  Dopamine; Induced pluripotent stem cells; Microtubule; Parkin; Parkinson's disease

Mesh:

Substances:

Year:  2015        PMID: 25332110      PMCID: PMC4429885          DOI: 10.1002/stem.1854

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  33 in total

Review 1.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

2.  PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria.

Authors:  Yun Chen; Gerald W Dorn
Journal:  Science       Date:  2013-04-26       Impact factor: 47.728

3.  Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells.

Authors:  Kye-Young Kim; Mark V Stevens; M Hasina Akter; Sarah E Rusk; Robert J Huang; Alexandra Cohen; Audrey Noguchi; Danielle Springer; Alexander V Bocharov; Tomas L Eggerman; Der-Fen Suen; Richard J Youle; Marcelo Amar; Alan T Remaley; Michael N Sack
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

4.  Selective vulnerability of dopaminergic neurons to microtubule depolymerization.

Authors:  Yong Ren; Wenhua Liu; Houbo Jiang; Qian Jiang; Jian Feng
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

5.  DJ-1 deficiency perturbs microtubule dynamics and impairs striatal neurite outgrowth.

Authors:  Chengyu Sheng; Xin Heng; Guannan Zhang; Ran Xiong; Hui Li; Shi Zhang; Shengdi Chen
Journal:  Neurobiol Aging       Date:  2012-05-19       Impact factor: 4.673

6.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

7.  Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.

Authors:  Yong Ren; Jinghui Zhao; Jian Feng
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

8.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

Review 9.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

10.  A direct interaction between leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin acetylation.

Authors:  Bernard M H Law; Victoria A Spain; Veronica H L Leinster; Ruth Chia; Alexandra Beilina; Hyun J Cho; Jean-Marc Taymans; Mary K Urban; Rosa M Sancho; Marian Blanca Ramírez; Saskia Biskup; Veerle Baekelandt; Huaibin Cai; Mark R Cookson; Daniel C Berwick; Kirsten Harvey
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

View more
  49 in total

1.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

Review 2.  Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.

Authors:  Xinwen Zhang; Di Hu; Yutong Shang; Xin Qi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-18       Impact factor: 5.187

Review 3.  Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs.

Authors:  Kurt R Brunden; Virginia M-Y Lee; Amos B Smith; John Q Trojanowski; Carlo Ballatore
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

Review 4.  Stem cells technology: a powerful tool behind new brain treatments.

Authors:  Lucienne N Duru; Zhenzhen Quan; Talal Jamil Qazi; Hong Qing
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 5.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

6.  Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.

Authors:  Bryan A Killinger; Anna Moszczynska
Journal:  J Neurochem       Date:  2015-12-10       Impact factor: 5.372

7.  Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy.

Authors:  Elisabetta Flex; Marcello Niceta; Serena Cecchetti; Isabelle Thiffault; Margaret G Au; Alessandro Capuano; Emanuela Piermarini; Anna A Ivanova; Joshua W Francis; Giovanni Chillemi; Balasubramanian Chandramouli; Giovanna Carpentieri; Charlotte A Haaxma; Andrea Ciolfi; Simone Pizzi; Ganka V Douglas; Kara Levine; Antonella Sferra; Maria Lisa Dentici; Rolph R Pfundt; Jean-Baptiste Le Pichon; Emily Farrow; Frank Baas; Fiorella Piemonte; Bruno Dallapiccola; John M Graham; Carol J Saunders; Enrico Bertini; Richard A Kahn; David A Koolen; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2016-09-22       Impact factor: 11.025

Review 8.  Microtubule Destabilization Paves the Way to Parkinson's Disease.

Authors:  D Cartelli; G Cappelletti
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

Review 9.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

Review 10.  Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.

Authors:  Xiaoyun Xu; Jinsha Huang; Jie Li; Ling Liu; Chao Han; Yan Shen; Guoxin Zhang; Haiyang Jiang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Cell Prolif       Date:  2016-01-08       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.